Efficacy of Diet on Quality of Life in Multiple Sclerosis
NCT05007483 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162
Last updated 2025-09-12
Summary
The overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of two dietary interventions (time restricted olive oil based (TROO) ketogenic and modified Paleolithic elimination) on MS QoL compared to usual care control (Dietary Guidelines for America), and the secondary objectives and the long-term effects on, motor function, low-contrast vision sensitivity, fatigue, mood, and disease activity assessed by brain imaging.
Conditions
- Multiple Sclerosis, Relapsing-Remitting
Interventions
- DIETARY_SUPPLEMENT
-
BodyBio Balance Oil
nutraceutical supplement
- DIETARY_SUPPLEMENT
-
Kirunal Fish Oil
nutraceutical supplement
- DIETARY_SUPPLEMENT
-
BodyBio PC
nutraceutical supplement
- BEHAVIORAL
-
Modified Paleolithic Elimination diet
1. Complete elimination of all gluten-, dairy-, and egg-containing foods. 2. Increase fruit and vegetable intake to 6-9 servings/day comprising of 2-3 servings each of the following categories: intensely colored, sulfur-rich, and leafy greens. 3. Consume 6-12 ounces/day protein including organ meats and fatty fish. 4. Consume fermented foods daily. 5. Consume daily servings of algae, seaweed, and nutritional yeast.
- BEHAVIORAL
-
Time Restricted Olive Oil Based (TROO) Ketogenic Diet
1. Restriction of dietary carbohydrates to \< 50 grams/day. 2. Use olive oil (cold-pressed extra virgin preferred) to increase fat intake to \>160 grams/day. 3. Consume \<100 grams/day protein. 4. Limit dairy to 2 servings/day of whole fat options (completely exclude reduced fat dairy). 5. Consume at least 3 servings/day non-starchy vegetables.
- BEHAVIORAL
-
Usual diet with Dietary Guidelines for Americans Diet information
1. Limit sodium to \< 2,300 mg/day. 2. Limit added sugar and saturated fat intake to \<10% of kcal/day, respectively. 3. Consume 5 servings of fruits and vegetables per day. 4. Consume 6-9 ounce equivalents/day of grains, making at least half whole grain options. 5. Consume 3 servings of reduced fat dairy per day. 6. Consume 6 ounces/day protein foods.
Sponsors & Collaborators
-
Terry L. Wahls
lead OTHER
Principal Investigators
-
Terry L Wahls, MD · University of Iowa
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-10
- Primary Completion
- 2026-09-01
- Completion
- 2026-12-01
Countries
- United States
Study Locations
More Related Trials
-
Natural Antioxidants in the Treatment of Multiple Sclerosis
NCT00010842 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multiple Sclerosis and the Effects of Ketogenic Diet Therapy
NCT06715436 ·Status: RECRUITING ·Phase: NA
-
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
NCT04009005 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Nutritional Approaches in Multiple Sclerosis
NCT03508414 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis
NCT02687919 ·Status: COMPLETED ·Phase: NA
-
Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis
NCT03740295 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Outcomes From Diets in Multiple Sclerosis
NCT05327322 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple Sclerosis
NCT05712408 ·Status: COMPLETED ·Phase: NA
-
Probiotic Intervention for People With Multiple Sclerosis
NCT07304713 ·Status: COMPLETED ·Phase: NA
-
Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS
NCT03718247 ·Status: COMPLETED
-
Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study
NCT02914964 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients
NCT06764563 ·Status: RECRUITING ·Phase: NA
-
Lipoic Acid for Progressive Multiple Sclerosis (MS)
NCT03161028 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis
NCT03172741 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
NCT01848327 ·Status: COMPLETED ·Phase: NA
-
A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis
NCT01538355 ·Status: COMPLETED ·Phase: NA
-
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
NCT01188811 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of DHA in Patients With Multiple Sclerosis
NCT07346703 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Wahls Paleo Diet and Progressive Multiple Sclerosis
NCT01915433 ·Status: COMPLETED ·Phase: NA
-
Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis
NCT03032601 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
NCT07346924 ·Status: COMPLETED ·Phase: NA
-
Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients
NCT02939079 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis
NCT03423121 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
NCT01466114 ·Status: UNKNOWN ·Phase: PHASE2
-
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis (Feasibility Study)
NCT04057066 ·Status: COMPLETED ·Phase: NA